Nature Biomedical Engineering-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2205281, encodeId=b3a622052816d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：18天了，啥消息也没有，效率太低，不建议投这个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/EFB87133DC263A8BF5CCC2B0E812D65B/100, createdBy=e45b2320274, createdName=飘忽小哥, createdTime=Fri May 17 20:08:56 CST 2024, time=2024-05-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2148780, encodeId=65f22148e805f, content=虽然建刊短短三年，但是难度如其它同等级杂志（如Nat. Electron., Nat. Catalysis等）一样，非常困难。为保证期刊论文质量，目前每周仅出版1-2篇研究论文，这样每年发表研究论文数在50-80篇之间。比2002年创刊的Nature Materials的发文量少一半以上。大量优秀的稿件还没见到审稿人就很快被礼貌的送回来了。首先编辑只对本期刊涉及的生医工领域关键的、新奇的突破与发现感兴趣，比如设计新颖的材料，方法，技术或疗法以抗击疾病，设计或优化现有的医疗器件和程序完成之前很难做到的任务，以及利用生物医学工程中的研究成果来评估患者的健康状况或在各种临床环境和医疗环境中进行治疗，并得到具有引领性、前瞻性的研究结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 19 13:11:23 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575209, encodeId=8c075e520924, content=投稿一周后被拒，不过也正常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPw6IFLuyxuUX3ia9UXIBCl5iaU2P8HnaZJNO7F3n16dVFibgj8r0GqFCl7ffQLka9zSukacUOxXL0w/132, createdBy=1d702090057, createdName=汪001, createdTime=Fri Aug 23 00:00:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802570, encodeId=3b038025e08d, content=今年的分比去年又升高了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Sun Jul 12 10:16:12 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801470, encodeId=34068014e007, content=今年投稿好难啊，哪里投，哪里都悲剧，害怕担心毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:51:46 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801469, encodeId=2b348014691b, content=集不齐CNS三大业内神刊，从CNS的子刊开始也是可以试一试的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:49:25 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801105, encodeId=f3678011051f, content=审稿速度:6.0 经验分享：审稿很严，注重研究新颖性和可靠性，审稿人提的意见一针见血。审稿速度比较慢，三次大修用了两年，假如没中，研究也不新颖了，就会狠心赛。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Fri Jul 03 19:39:43 CST 2020, time=2020-07-03, status=1, ipAttribution=)]

2024-05-17 飘忽小哥来自北京

审稿速度:2.0 | 投稿命中率:25.0
经验分享：18天了，啥消息也没有，效率太低，不建议投这个期刊。

71 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205281, encodeId=b3a622052816d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：18天了，啥消息也没有，效率太低，不建议投这个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/EFB87133DC263A8BF5CCC2B0E812D65B/100, createdBy=e45b2320274, createdName=飘忽小哥, createdTime=Fri May 17 20:08:56 CST 2024, time=2024-05-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2148780, encodeId=65f22148e805f, content=虽然建刊短短三年，但是难度如其它同等级杂志（如Nat. Electron., Nat. Catalysis等）一样，非常困难。为保证期刊论文质量，目前每周仅出版1-2篇研究论文，这样每年发表研究论文数在50-80篇之间。比2002年创刊的Nature Materials的发文量少一半以上。大量优秀的稿件还没见到审稿人就很快被礼貌的送回来了。首先编辑只对本期刊涉及的生医工领域关键的、新奇的突破与发现感兴趣，比如设计新颖的材料，方法，技术或疗法以抗击疾病，设计或优化现有的医疗器件和程序完成之前很难做到的任务，以及利用生物医学工程中的研究成果来评估患者的健康状况或在各种临床环境和医疗环境中进行治疗，并得到具有引领性、前瞻性的研究结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 19 13:11:23 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575209, encodeId=8c075e520924, content=投稿一周后被拒，不过也正常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPw6IFLuyxuUX3ia9UXIBCl5iaU2P8HnaZJNO7F3n16dVFibgj8r0GqFCl7ffQLka9zSukacUOxXL0w/132, createdBy=1d702090057, createdName=汪001, createdTime=Fri Aug 23 00:00:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802570, encodeId=3b038025e08d, content=今年的分比去年又升高了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Sun Jul 12 10:16:12 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801470, encodeId=34068014e007, content=今年投稿好难啊，哪里投，哪里都悲剧，害怕担心毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:51:46 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801469, encodeId=2b348014691b, content=集不齐CNS三大业内神刊，从CNS的子刊开始也是可以试一试的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:49:25 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801105, encodeId=f3678011051f, content=审稿速度:6.0 经验分享：审稿很严，注重研究新颖性和可靠性，审稿人提的意见一针见血。审稿速度比较慢，三次大修用了两年，假如没中，研究也不新颖了，就会狠心赛。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Fri Jul 03 19:39:43 CST 2020, time=2020-07-03, status=1, ipAttribution=)]

2023-07-19 ms1000000582868380 来自浙江省

虽然建刊短短三年，但是难度如其它同等级杂志（如Nat. Electron., Nat. Catalysis等）一样，非常困难。为保证期刊论文质量，目前每周仅出版1-2篇研究论文，这样每年发表研究论文数在50-80篇之间。比2002年创刊的Nature Materials的发文量少一半以上。大量优秀的稿件还没见到审稿人就很快被礼貌的送回来了。首先编辑只对本期刊涉及的生医工领域关键的、新奇的突破与发现感兴趣，比如设计新颖的材料，方法，技术或疗法以抗击疾病，设计或优化现有的医疗器件和程序完成之前很难做到的任务，以及利用生物医学工程中的研究成果来评估患者的健康状况或在各种临床环境和医疗环境中进行治疗，并得到具有引领性、前瞻性的研究结果。

112 0

[GetPortalCommentsPageByObjectIdResponse(id=2205281, encodeId=b3a622052816d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：18天了，啥消息也没有，效率太低，不建议投这个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/EFB87133DC263A8BF5CCC2B0E812D65B/100, createdBy=e45b2320274, createdName=飘忽小哥, createdTime=Fri May 17 20:08:56 CST 2024, time=2024-05-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2148780, encodeId=65f22148e805f, content=虽然建刊短短三年，但是难度如其它同等级杂志（如Nat. Electron., Nat. Catalysis等）一样，非常困难。为保证期刊论文质量，目前每周仅出版1-2篇研究论文，这样每年发表研究论文数在50-80篇之间。比2002年创刊的Nature Materials的发文量少一半以上。大量优秀的稿件还没见到审稿人就很快被礼貌的送回来了。首先编辑只对本期刊涉及的生医工领域关键的、新奇的突破与发现感兴趣，比如设计新颖的材料，方法，技术或疗法以抗击疾病，设计或优化现有的医疗器件和程序完成之前很难做到的任务，以及利用生物医学工程中的研究成果来评估患者的健康状况或在各种临床环境和医疗环境中进行治疗，并得到具有引领性、前瞻性的研究结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 19 13:11:23 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575209, encodeId=8c075e520924, content=投稿一周后被拒，不过也正常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPw6IFLuyxuUX3ia9UXIBCl5iaU2P8HnaZJNO7F3n16dVFibgj8r0GqFCl7ffQLka9zSukacUOxXL0w/132, createdBy=1d702090057, createdName=汪001, createdTime=Fri Aug 23 00:00:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802570, encodeId=3b038025e08d, content=今年的分比去年又升高了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Sun Jul 12 10:16:12 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801470, encodeId=34068014e007, content=今年投稿好难啊，哪里投，哪里都悲剧，害怕担心毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:51:46 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801469, encodeId=2b348014691b, content=集不齐CNS三大业内神刊，从CNS的子刊开始也是可以试一试的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:49:25 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801105, encodeId=f3678011051f, content=审稿速度:6.0 经验分享：审稿很严，注重研究新颖性和可靠性，审稿人提的意见一针见血。审稿速度比较慢，三次大修用了两年，假如没中，研究也不新颖了，就会狠心赛。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Fri Jul 03 19:39:43 CST 2020, time=2020-07-03, status=1, ipAttribution=)]

2019-08-23 汪001

投稿一周后被拒，不过也正常

326 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205281, encodeId=b3a622052816d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：18天了，啥消息也没有，效率太低，不建议投这个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/EFB87133DC263A8BF5CCC2B0E812D65B/100, createdBy=e45b2320274, createdName=飘忽小哥, createdTime=Fri May 17 20:08:56 CST 2024, time=2024-05-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2148780, encodeId=65f22148e805f, content=虽然建刊短短三年，但是难度如其它同等级杂志（如Nat. Electron., Nat. Catalysis等）一样，非常困难。为保证期刊论文质量，目前每周仅出版1-2篇研究论文，这样每年发表研究论文数在50-80篇之间。比2002年创刊的Nature Materials的发文量少一半以上。大量优秀的稿件还没见到审稿人就很快被礼貌的送回来了。首先编辑只对本期刊涉及的生医工领域关键的、新奇的突破与发现感兴趣，比如设计新颖的材料，方法，技术或疗法以抗击疾病，设计或优化现有的医疗器件和程序完成之前很难做到的任务，以及利用生物医学工程中的研究成果来评估患者的健康状况或在各种临床环境和医疗环境中进行治疗，并得到具有引领性、前瞻性的研究结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 19 13:11:23 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575209, encodeId=8c075e520924, content=投稿一周后被拒，不过也正常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPw6IFLuyxuUX3ia9UXIBCl5iaU2P8HnaZJNO7F3n16dVFibgj8r0GqFCl7ffQLka9zSukacUOxXL0w/132, createdBy=1d702090057, createdName=汪001, createdTime=Fri Aug 23 00:00:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802570, encodeId=3b038025e08d, content=今年的分比去年又升高了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Sun Jul 12 10:16:12 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801470, encodeId=34068014e007, content=今年投稿好难啊，哪里投，哪里都悲剧，害怕担心毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:51:46 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801469, encodeId=2b348014691b, content=集不齐CNS三大业内神刊，从CNS的子刊开始也是可以试一试的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:49:25 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801105, encodeId=f3678011051f, content=审稿速度:6.0 经验分享：审稿很严，注重研究新颖性和可靠性，审稿人提的意见一针见血。审稿速度比较慢，三次大修用了两年，假如没中，研究也不新颖了，就会狠心赛。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Fri Jul 03 19:39:43 CST 2020, time=2020-07-03, status=1, ipAttribution=)]

2020-07-12 快点发一篇SCI

今年的分比去年又升高了。

299 0

[GetPortalCommentsPageByObjectIdResponse(id=2205281, encodeId=b3a622052816d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：18天了，啥消息也没有，效率太低，不建议投这个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/EFB87133DC263A8BF5CCC2B0E812D65B/100, createdBy=e45b2320274, createdName=飘忽小哥, createdTime=Fri May 17 20:08:56 CST 2024, time=2024-05-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2148780, encodeId=65f22148e805f, content=虽然建刊短短三年，但是难度如其它同等级杂志（如Nat. Electron., Nat. Catalysis等）一样，非常困难。为保证期刊论文质量，目前每周仅出版1-2篇研究论文，这样每年发表研究论文数在50-80篇之间。比2002年创刊的Nature Materials的发文量少一半以上。大量优秀的稿件还没见到审稿人就很快被礼貌的送回来了。首先编辑只对本期刊涉及的生医工领域关键的、新奇的突破与发现感兴趣，比如设计新颖的材料，方法，技术或疗法以抗击疾病，设计或优化现有的医疗器件和程序完成之前很难做到的任务，以及利用生物医学工程中的研究成果来评估患者的健康状况或在各种临床环境和医疗环境中进行治疗，并得到具有引领性、前瞻性的研究结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 19 13:11:23 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575209, encodeId=8c075e520924, content=投稿一周后被拒，不过也正常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPw6IFLuyxuUX3ia9UXIBCl5iaU2P8HnaZJNO7F3n16dVFibgj8r0GqFCl7ffQLka9zSukacUOxXL0w/132, createdBy=1d702090057, createdName=汪001, createdTime=Fri Aug 23 00:00:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802570, encodeId=3b038025e08d, content=今年的分比去年又升高了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Sun Jul 12 10:16:12 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801470, encodeId=34068014e007, content=今年投稿好难啊，哪里投，哪里都悲剧，害怕担心毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:51:46 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801469, encodeId=2b348014691b, content=集不齐CNS三大业内神刊，从CNS的子刊开始也是可以试一试的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:49:25 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801105, encodeId=f3678011051f, content=审稿速度:6.0 经验分享：审稿很严，注重研究新颖性和可靠性，审稿人提的意见一针见血。审稿速度比较慢，三次大修用了两年，假如没中，研究也不新颖了，就会狠心赛。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Fri Jul 03 19:39:43 CST 2020, time=2020-07-03, status=1, ipAttribution=)]

2020-07-06 快点发一篇SCI

今年投稿好难啊，哪里投，哪里都悲剧，害怕担心毕业

300 0

[GetPortalCommentsPageByObjectIdResponse(id=2205281, encodeId=b3a622052816d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：18天了，啥消息也没有，效率太低，不建议投这个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/EFB87133DC263A8BF5CCC2B0E812D65B/100, createdBy=e45b2320274, createdName=飘忽小哥, createdTime=Fri May 17 20:08:56 CST 2024, time=2024-05-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2148780, encodeId=65f22148e805f, content=虽然建刊短短三年，但是难度如其它同等级杂志（如Nat. Electron., Nat. Catalysis等）一样，非常困难。为保证期刊论文质量，目前每周仅出版1-2篇研究论文，这样每年发表研究论文数在50-80篇之间。比2002年创刊的Nature Materials的发文量少一半以上。大量优秀的稿件还没见到审稿人就很快被礼貌的送回来了。首先编辑只对本期刊涉及的生医工领域关键的、新奇的突破与发现感兴趣，比如设计新颖的材料，方法，技术或疗法以抗击疾病，设计或优化现有的医疗器件和程序完成之前很难做到的任务，以及利用生物医学工程中的研究成果来评估患者的健康状况或在各种临床环境和医疗环境中进行治疗，并得到具有引领性、前瞻性的研究结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 19 13:11:23 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575209, encodeId=8c075e520924, content=投稿一周后被拒，不过也正常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPw6IFLuyxuUX3ia9UXIBCl5iaU2P8HnaZJNO7F3n16dVFibgj8r0GqFCl7ffQLka9zSukacUOxXL0w/132, createdBy=1d702090057, createdName=汪001, createdTime=Fri Aug 23 00:00:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802570, encodeId=3b038025e08d, content=今年的分比去年又升高了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Sun Jul 12 10:16:12 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801470, encodeId=34068014e007, content=今年投稿好难啊，哪里投，哪里都悲剧，害怕担心毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:51:46 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801469, encodeId=2b348014691b, content=集不齐CNS三大业内神刊，从CNS的子刊开始也是可以试一试的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:49:25 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801105, encodeId=f3678011051f, content=审稿速度:6.0 经验分享：审稿很严，注重研究新颖性和可靠性，审稿人提的意见一针见血。审稿速度比较慢，三次大修用了两年，假如没中，研究也不新颖了，就会狠心赛。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Fri Jul 03 19:39:43 CST 2020, time=2020-07-03, status=1, ipAttribution=)]

2020-07-06 快点发一篇SCI

集不齐CNS三大业内神刊，从CNS的子刊开始也是可以试一试的

341 0

[GetPortalCommentsPageByObjectIdResponse(id=2205281, encodeId=b3a622052816d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：18天了，啥消息也没有，效率太低，不建议投这个期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/EFB87133DC263A8BF5CCC2B0E812D65B/100, createdBy=e45b2320274, createdName=飘忽小哥, createdTime=Fri May 17 20:08:56 CST 2024, time=2024-05-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2148780, encodeId=65f22148e805f, content=虽然建刊短短三年，但是难度如其它同等级杂志（如Nat. Electron., Nat. Catalysis等）一样，非常困难。为保证期刊论文质量，目前每周仅出版1-2篇研究论文，这样每年发表研究论文数在50-80篇之间。比2002年创刊的Nature Materials的发文量少一半以上。大量优秀的稿件还没见到审稿人就很快被礼貌的送回来了。首先编辑只对本期刊涉及的生医工领域关键的、新奇的突破与发现感兴趣，比如设计新颖的材料，方法，技术或疗法以抗击疾病，设计或优化现有的医疗器件和程序完成之前很难做到的任务，以及利用生物医学工程中的研究成果来评估患者的健康状况或在各种临床环境和医疗环境中进行治疗，并得到具有引领性、前瞻性的研究结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 19 13:11:23 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=575209, encodeId=8c075e520924, content=投稿一周后被拒，不过也正常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPw6IFLuyxuUX3ia9UXIBCl5iaU2P8HnaZJNO7F3n16dVFibgj8r0GqFCl7ffQLka9zSukacUOxXL0w/132, createdBy=1d702090057, createdName=汪001, createdTime=Fri Aug 23 00:00:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802570, encodeId=3b038025e08d, content=今年的分比去年又升高了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Sun Jul 12 10:16:12 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801470, encodeId=34068014e007, content=今年投稿好难啊，哪里投，哪里都悲剧，害怕担心毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:51:46 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801469, encodeId=2b348014691b, content=集不齐CNS三大业内神刊，从CNS的子刊开始也是可以试一试的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:49:25 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801105, encodeId=f3678011051f, content=审稿速度:6.0 经验分享：审稿很严，注重研究新颖性和可靠性，审稿人提的意见一针见血。审稿速度比较慢，三次大修用了两年，假如没中，研究也不新颖了，就会狠心赛。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Fri Jul 03 19:39:43 CST 2020, time=2020-07-03, status=1, ipAttribution=)]

2020-07-03 快点发一篇SCI

审稿速度:6.0
经验分享：审稿很严，注重研究新颖性和可靠性，审稿人提的意见一针见血。审稿速度比较慢，三次大修用了两年，假如没中，研究也不新颖了，就会狠心赛。。

318 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务